NCT02043015

Brief Summary

The purpose of this study is to evaluate the acceptability and uptake of a combination package of biomedical, behavioral and community-level HIV prevention interventions and services for men who have sex with men (MSM) in South Africa.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Feb 2015

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 23, 2014

Completed
1 year until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
11 months until next milestone

Results Posted

Study results publicly available

January 17, 2018

Completed
Last Updated

September 17, 2018

Status Verified

September 1, 2018

Enrollment Period

1.7 years

First QC Date

January 21, 2014

Results QC Date

October 19, 2017

Last Update Submit

September 13, 2018

Conditions

Keywords

voluntary counseling and testing (VCT)couples voluntary counseling and testing (CVCT)pre-exposure prophylaxis (PrEP)homosexualitymaleSouth Africa

Outcome Measures

Primary Outcomes (3)

  • Retention in the Cohort

    The ability of the study to retain participants for full study period was assessed. Retention was measured by the number and percentage of enrolled participants attending study visits through the 12-month study period.

    12 months

  • Use of PrEP

    Uptake of PrEP by study participants was measured as the number and percentage of enrolled participants eligible for PrEP at the baseline and 3-month study visits who choose to initiate PrEP at a visit one month later.

    4 months

  • Number of Participants With New HIV Infection

    Incident HIV infection is measured as the number of seroconversions during follow-up among those who are HIV-uninfected at baseline.

    12 months

Secondary Outcomes (7)

  • Condom Use

    Months 3, 6, and 12

  • Lubricant Use

    Months 3, 6, and 12

  • Voluntary Counseling and Testing (VCT) and Couples Voluntary Counseling and Testing (CVCT) Uptake

    12 months

  • Number of HIV Tests During Study

    12 months

  • Serodiscordant Unprotected Anal Intercourse (UAI)

    Month 3, 6, and 12

  • +2 more secondary outcomes

Study Arms (1)

Comprehensive HIV prevention services

OTHER

A comprehensive package of HIV prevention services, including condom choices, Condom-compatible lubricant choices, Couples HIV counseling and testing (CVCT), Staff and provider MSM and LGBT sensitization training, HIV Testing and Risk-reduction counseling, Linkage to care, Pre-exposure prophylaxis with FTC/TDF

Behavioral: Condom choicesBehavioral: Condom-compatible lubricant choicesBehavioral: Couples HIV counseling and testing (CVCT)Drug: Pre-exposure prophylaxis with FTC/TDFOther: Staff and provider MSM and LGBT sensitization trainingBehavioral: HIV Testing and Risk-reduction counselingBehavioral: Linkage to care

Interventions

Condom choicesBEHAVIORAL

Men will receive the condom package that includes an assortment of styles, sizes, features and colors at their baseline visit, and will be able to get more condoms for free at any time after that visit by coming to a study clinic during clinic hours, or during a scheduled study visit.

Comprehensive HIV prevention services

Men will receive condom-compatible lubricant that will include different types of lubricant (e.g., silicone-based) and different packaging (individual sachets or flat, discreet packages) at their baseline study visit, and participants will be able to access enhanced condom-compatible lubricant at any time after that visit by coming to a study clinic during clinic hours, or during a scheduled study visit.

Comprehensive HIV prevention services

Participants will be invited to schedule couples voluntary HIV counseling and testing (CVCT) appointments with a clinic counselor at any point after they complete their baseline study visit.

Comprehensive HIV prevention services

For men who meet eligibility criteria, PrEP with Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) will be made available beginning one month into the study. Men who express interest and meet eligibility criteria at their baseline visit can initiate PrEP at 1 month if they test negative for HIV. For men with extenuating circumstances, whose risk profile changes, of those who become more comfortable with the PrEP intervention through enrollment in the study, PrEP will be available to initiate at the 4 month visit. Men who accept PrEP will be required to have clinic visits, in addition to the regularly scheduled study visits, one month after starting PrEP and at least every 3 months afterward to monitor blood creatinine, AST/ALT and phosphorus levels.

Also known as: PrEP
Comprehensive HIV prevention services

The training for clinicians will focus on specific sexual health issues for MSM, including taking sexual histories in a non-judgmental way, physical examination techniques including anal examinations, and collection of rectal swabs for STI testing. Trainings will include topics about stigma, sexual identity and coming out, anal sex, STIs, and mental health. Training on LGBT sensitization will be provided for medical providers and staff in target clinics.

Comprehensive HIV prevention services

Risk-reduction counseling will be provided to all men at baseline and additionally at 3, 6, and 12 month visits, with an additional counseling session for men on PrEP at their initiation visit (either month 1 or 4), their 1-month follow-up visit (either month 2 or 5) and at their 9 month visit. Risk reduction counseling will be client-centered counseling, according to CDC's Fundamentals of HIV Prevention Counseling protocol.

Comprehensive HIV prevention services
Linkage to careBEHAVIORAL

Men will be linked to needed services including HIV care and treatment for positives identified at baseline or during the study, including antiretroviral medications, and mental health services. At the end of their baseline visit, participants will receive service referral handouts for HIV care and treatment, mental health services, and other resources, as appropriate. Men who test positive for STIs will be treated at the clinic site.

Comprehensive HIV prevention services

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male sex at birth
  • Anal sex with another man in the past 12 months
  • years of age or older
  • Resident of the study city
  • Able to complete study instruments, with or without assistance, in English, Xhosa or Afrikaans
  • Willing to provide contact information
  • Has a phone

You may not qualify if:

  • Not male sex at birth
  • No self-reported anal sex with a man in the past 12 months
  • Less than 18 years of age
  • Not a resident of the study city
  • Plans to move from the study city within the year after enrollment
  • Not able to complete study instructions, with or without assistance, in English, Xhosa or Afrikaans
  • Not willing to provide contact information
  • Does not have a phone
  • Identified as high-risk for HIV by the provider by meeting one or more of the criteria below:
  • Have multiple partners
  • Engage in transactional sex, including sex workers
  • Use or abuse drugs
  • Drink alcohol heavily
  • Had more than 1 episode of a STI in the last year
  • Is the HIV-negative partner in a discordant relationship, especially if the HIV-positive partner is not on antiretroviral therapy (ART)
  • +20 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rollins School of Public Health

Atlanta, Georgia, 30322, United States

Location

Johns Hopkins School of Public Health

Baltimore, Maryland, 21205, United States

Location

Desmond Tutu HIV Foundation

Cape Town, South Africa

Location

Related Publications (1)

  • McNaghten A, Kearns R, Siegler AJ, Phaswana-Mafuya N, Bekker LG, Stephenson R, Baral SD, Brookmeyer R, Yah CS, Lambert AJ, Brown B, Rosenberg E, Blalock Tharp M, de Voux A, Beyrer C, Sullivan PS. Sibanye Methods for Prevention Packages Program Project Protocol: Pilot Study of HIV Prevention Interventions for Men Who Have Sex With Men in South Africa. JMIR Res Protoc. 2014 Oct 16;3(4):e55. doi: 10.2196/resprot.3737.

MeSH Terms

Conditions

Homosexuality

Interventions

Pre-Exposure ProphylaxisHIV Testing

Condition Hierarchy (Ancestors)

SexualitySexual BehaviorBehavior

Intervention Hierarchy (Ancestors)

Primary PreventionPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPublic Health PracticePublic HealthEnvironment and Public HealthMicrobiological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Results Point of Contact

Title
Patrick S Sullivan PhD/DVM
Organization
Emory University

Study Officials

  • Patrick S Sulivan, DVM, PhD

    Rollins School of Public Health

    PRINCIPAL INVESTIGATOR
  • A.D. McNaghten, PhD, MHSA

    Rollins School of Public Health

    PRINCIPAL INVESTIGATOR
  • Stefan Baral, MD, MPH

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR
  • Linda-Gail Bekker, MBChB, PhD

    Desmond Tutu HIV Foundation

    PRINCIPAL INVESTIGATOR
  • Rob Stephenson, MSc, PhD

    Rollins School of Public Health

    PRINCIPAL INVESTIGATOR
  • Chris Beyrer, MD, MPH

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 21, 2014

First Posted

January 23, 2014

Study Start

February 1, 2015

Primary Completion

October 1, 2016

Study Completion

March 1, 2017

Last Updated

September 17, 2018

Results First Posted

January 17, 2018

Record last verified: 2018-09

Locations